| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000015535 |
| Receipt No. | R000018048 |
| Official scientific title of the study | To investigate the effect of the humidifying device in a driving simulator on driving performance and visual function |
| Date of disclosure of the study information | 2014/10/27 |
| Last modified on | 2016/04/09 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | To investigate the effect of the humidifying device in a driving simulator on driving performance and visual function | |
| Title of the study (Brief title) | To investigate the effect of the humidifying device in a driving simulator on driving performance and visual function | |
| Region |
|
|
| Condition | ||
| Condition | dry eye/Healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of the humidified environment on dry eye and fatigue assosiated with driving |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Ocular surface parameters (symptoms,BUT, Fluorescein staining score, tear meniscus volume, functional visual acuity, CFF) |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | humidifying device(+) | |
| Interventions/Control_2 | humidifying device(-) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | people who drive more then once a week | |||
| Key exclusion criteria | claustrophobic patient
patients who is under treatment of orthopedic or ocular diseases contact lens wearers during experiment people who have an allergy against alcohol or surgical tapes people with a history of epilepsia |
|||
| Target sample size | 16 | |||
| Research contact person | |
| Name of lead principal investigator | Motoko Kawashima |
| Organization | Keio University School of Medicine |
| Division name | Department of Ophthalmology |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan |
| TEL | 81333531211 |
| motoko326@gmail.com | |
| Public contact | |
| Name of contact person | Motoko Kawashima |
| Organization | Keio University School of Medicine |
| Division name | Ophthalmology |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan |
| TEL | 81333531211(63954) |
| Homepage URL | |
| motoko326@gmail.com | |
| Sponsor | |
| Institute | Department of Ophthalmology, Keio University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | DENSO CORPORATION |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000018048 |